Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia

ClinicalTrials.gov ID: NCT02832037

Public ClinicalTrials.gov record NCT02832037. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 1:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Randomised, Double-blinded, Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of 4 Oral Doses of BI 425809 Once Daily Over 12 Week Treatment Period in Patients With Schizophrenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of the study is to investigate the efficacy, safety and pharmacokinetics of four different doses of BI 425809 once daily compared to placebo given for 12 weeks in patients with schizophrenia on stable antipsychotic treatment.

Study identification

NCT ID
NCT02832037
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
509 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 24, 2016
Primary completion
Dec 26, 2019
Completion
Jan 28, 2020
Last update posted
Feb 23, 2021

2016 – 2020

United States locations

U.S. sites
21
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Collaborative Neuroscience Network, LLC (CNS) Garden Grove California 92845
Synergy San Diego Lemon Grove California 91945
NRC Research Institute Orange California 92868
Alliance for Wellness Panorama City California 91402
CNRI - Los Angeles Pico Rivera California 90660
CNRI-San Diego, LLC San Diego California 92102
Premier Clinical Research Institute Miami Florida 33122
Synexus Atlanta Georgia 30328
Atlanta Center Atlanta Georgia 30331
Uptown Research Institute Chicago Illinois 60640
Lake Charles Clinical Trials LLC Lake Charles Louisiana 70629
Michigan Clinical Research Institute PC Ann Arbor Michigan 48105
Mid-America Clinical Research, LLC St Louis Missouri 63109
University at Buffalo, The State University of New York Buffalo New York 14215
Neurobehavioral Research, Inc. Cedarhurst New York 11516
Finger Lakes Clinical Research Rochester New York 14618
North Carolina Psychiatric Research Center Raleigh North Carolina 27610
Midwest Clinical Research Dayton Ohio 45417
InSite Clinical Research DeSoto Texas 75115
Psychiatric and Behavioral Solutions, LLC Salt Lake City Utah 84105
Northwest Clinical Research Center Bellevue Washington 98007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02832037, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 23, 2021 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02832037 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →